Study Evaluating Efficacy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Evaluating Efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Evaluating Efficacy Today - Breaking & Trending Today

Positive Data Demonstrates Gepotidacin is Non-Inferior to Alternative Treatment in GC

Published: April 19, 2024

In a trial that compared gepotidacin to ceftriaxone plus azithromycin in patients with urogenital gonorrhea, gepotidacin presented a 92.6% microbiological success rate.

Source: pharmacytimes.com

Related Topics:

Comunidad Autonoma De CatalunaChris CorsicoEuropean Society Of Clinical MicrobiologyEuropean CongressStudy Evaluating EfficacyUncomplicated UrogenitalEuropean SocietyClinical MicrobiologyInfectious Diseases GlobalInfectious Diseases

Gepotidacin Demonstrates Non-Inferiority Treating Uncomplicated Urogenital Gonorrhea in Phase 3 Trial

Published: February 27, 2024

Gepotidacin was compared with the combination of ceftriaxone and azithromycin in adolescent and adult patients with uncomplicated urogenital gonorrhea.

Source: pharmacytimes.com

Related Topics:

Chris CorsicoAntibacterial Gepotidacin EvaluatedOpen Label StudyAdult Participants ComparingCeftriaxone Plus AzithromycinUncomplicated Urogenital Gonorrhea CausedEvaluate EfficacyUncomplicated Urinary Tract InfectionComparative StudyStudy Evaluating EfficacyUncomplicated Urogenital Gonorrhea Clinicaltrials